Skip to content
  • Tuesday, 27 October 2026
  • 4:20 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Discovery of Fam102a Protein as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment
Stem Cell & Regenerative Medicine

Discovery of Fam102a Protein as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment

Dwi Wanna May 24, 2026 0

A breakthrough study led by researchers at the Institute of Science Tokyo has identified a critical protein, Fam102a (Family with…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator in Bone Remodeling Offers New Pathways for Osteoporosis Treatment

Dwi Wanna May 17, 2026 0

In a significant advancement for regenerative medicine and skeletal health, a team of researchers at the Institute of Science Tokyo…

Read More
Stem Cell & Regenerative Medicine

Inflammatory Remodeling of the Bone Marrow Niche Drives Early Progression of Myelodysplastic Syndromes and Clonal Hematopoiesis

Dwi Wanna May 16, 2026 0

Every second of every day, the human bone marrow performs a silent biological miracle, generating millions of fresh blood and…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a Protein as a Novel Bone Remodeling Factor Offers New Pathway for Osteoporosis Treatment

Dwi Wanna May 9, 2026 0

In a landmark study published in the journal Nature Communications on January 2, 2025, a research team led by Professor…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator in Bone Remodeling Offers New Pathways for Osteoporosis Treatment

Dwi Wanna May 1, 2026 0

In a landmark study that could redefine the clinical approach to metabolic bone diseases, a research team led by Professor…

Read More
Stem Cell & Regenerative Medicine

Inflammatory Remodeling of the Bone Marrow Niche Drives Early Progression of Clonal Hematopoiesis and Myelodysplastic Syndromes

Dwi Wanna May 1, 2026 0

The human bone marrow is one of the most industrious organs in the body, serving as a biological factory that…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment

Dwi Wanna Apr 23, 2026 0

In a landmark study that promises to redefine the landscape of musculoskeletal medicine, researchers at the Institute of Science Tokyo…

Read More
Stem Cell & Regenerative Medicine

Inflammatory Remodeling of the Bone Marrow Niche: New Insights into the Early Drivers of Myelodysplastic Syndromes and Clonal Hematopoiesis

Dwi Wanna Apr 16, 2026 0

The human bone marrow is one of the most industrious environments in the human body, functioning as a biological factory…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator of Bone Remodeling Offers New Pathways for Osteoporosis Treatment

Dwi Wanna Apr 16, 2026 0

The intricate balance of the human skeletal system relies on a continuous cycle of renewal known as bone remodeling, a…

Read More
Stem Cell & Regenerative Medicine

Bone Marrow Microenvironment Remodeling Identified as Primary Driver in the Progression of Clonal Hematopoiesis and Myelodysplastic Syndromes

Dwi Wanna Apr 9, 2026 0

The human bone marrow functions as a biological factory of staggering proportions, generating millions of new blood and immune cells…

Read More

Posts pagination

1 2 3
Bistrifluron: A Promising New Chemical Offers Targeted Defense Against Destructive Drywood TermitesRemepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s.Science News: A Century of Empowering Public Understanding of ScienceNovo Nordisk’s triple agonist delivers up to 19.7% average weight loss in Phase 2 trial
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ